Methicillin-resistant staphylococci biofilms and the possibility of controlling them with chlorhexidine and polyhexanide: prospects for use in real clinical practice
https://doi.org/10.37489/2782-3784-myrwd-075
EDN: NXKLWD
Abstract
Introduction. The leading pathogens of implant-associated infection are S. aureus and S. epidermidis, characterized by the ability to biofilm formation, which pose a serious threat to the life and health of patients. Antibiotic therapy is an integral part of the complex treatment of infection, but washing the surgical area after the removal of infected components with antiseptics, including those based on polyhexanide or chlorhexidine, plays a major role.
Objective. To evaluate the presence of biofilm-forming genes in methicillin-resistant S. aureus and S. epidermidis isolated from patients with orthopedic infection and to perform a comparative analysis of the effect of chlorhexidine and polyhexanide on their biofilms.
Materials and methods. Cultures were isolated according to the international standards of microbiological research. Identification was performed by MALDI-TOF MS, and antibiotic susceptibility was determined according to EUCAST. DNA was isolated and purified using Auto-Pure S32 and the Magno-Sorb kit. Amplification was performed on a CFX-96 device. Visualization was performed using the ChemiDoc gel documentation system. Biofilms were formed for 48 hours and then treated with polyhexanide or chlorhexidine for 5, 10, 20, 40 minutes. The destructive effect of the antiseptics was determined by staining with gentian violet and subsequent comparison with the control. The presence of live bacterial cells in the biofilm after treatment with the drugs was assessed using a resazurin sodium salt. Statistical analysis was performed in GraphPad Prism 9.0.
Results. The bap gene was detected, and no ica-operon genes were found. MRSA were characterized by the presence of 3 marker genes, and MRSE strains had one or two marker genes. Polyhexanide was more effective in destroying the biomass of the formed daily biofilms of S. aureus — carriers of the bap, clfA/B genes, in contrast to chlorhexidine. Polyhexanide statistically significantly reduced the biomass with an exposure of more than 10 minutes. A similar pattern was found for the MRSE biofilms. In addition, the drugs almost destroyed the biofilm cells of MRSE, and polyhexanide was more effective against MRSA.
Conclusion. The study revealed the main genetic determinants of methicillin-resistant S. aureus and S. epidermidis biofilm formation. The established interspecies genetic differences can determine the effectiveness of antiseptics and demonstrate the need for exposure of the studied antiseptic for at least 20 minutes to achieve maximum effect on the biofilm cells of staphylococci.
About the Authors
E. M. GordinaRussian Federation
Ekaterina M. Gordina, Cand. Sci. (Med.), Senior Researcher
Department of Prevention and Treatment of Wound Infection
St. Petersburg
Competing Interests:
The authors declare no conflict of interest
A. D. Shakhmatova
Russian Federation
Alexandra D. Shakhmatova, biologist
Department of Clinical Pharmacology
St. Petersburg
Competing Interests:
The authors declare no conflict of interest
A. R. Kasimova
Russian Federation
Alina R. Kasimova, Cand. Sci. (Med.), associate professor, Clinical pharmacologist
department of Clinical Pharmacology and Evidence-Based Medicine; Department of Clinical Pharmacology
St. Petersburg
Competing Interests:
The authors declare no conflict of interest
S. S. Toropov
Russian Federation
Sergey S. Toropov, surgeon-traumatologist
Department of Purulent Osteology
St. Petersburg
Competing Interests:
The authors declare no conflict of interest
S. A. Bozhkova
Russian Federation
Svetlana A. Bozhkova, MD, PhD, Head of the Department, Professor
Scientific Department of Prevention and Treatment of Wound Infection; Department of Clinical Pharmacology; Department of Traumatology and Orthopedics
St. Petersburg
Competing Interests:
The authors declare no conflict of interest
References
1. Samelis P, Papagrigorakis E, Sameli E, Mavrogenis A, Savvidou O, Koulouvaris P. Current concepts on the application, pharmacokinetics and complications of antibiotic loaded cement spacers in the treatment of prosthetic joint infections. Cureus. 2022;14(1):e20968. doi: 10.7759/cureus.20968.
2. Kasimova A.R., Tufanova O.S., Gordina E.M., Gvozdetsky A.N., Radaeva K.S., Rukina A.N., Bozhkova S.A., Tikhilov R.M. Twelve-year dynamics of the spectrum of leading pathogens of orthopedic infection : a retrospective study. Traumatology and Orthopedics of Russia. 2024;30(1):6675 (in Russ.). doi: 10.17816/2311290516720.
3. Lyubimova L.V., Pchelova N.N., Nikolaev N.S., Preobrazhenskaya E.V., Lyubimov E.A. Microbiological profile of patients with orthopedic implant-associated infection in the post-COVID period. Acta Biomedica Scientifica. 2024;9(3):203-212. doi: 10.29413/ABS.2024-9.3.20 (in Russ.)
4. Fröschen FS, Randau TM, Franz A, Molitor E, Hischebeth GTR. Microbiological profiles of patients with periprosthetic joint infection of the hip or knee. Diagnostics (Basel). 2022; 12(7): 1654. doi: 10.3390/diagnostics12071654
5. François P, Schrenzel J, Götz F. Biology and Regulation of Staphylococcal Biofilm. Int J Mol Sci. 2023;24(6):5218. doi: 10.3390/ijms24065218.
6. Peng Q, Tang X, Dong W, Sun N, Yuan W. A Review of Biofilm Formation of Staphylococcus aureus and Its Regulation Mechanism. Antibiotics (Basel). 2022;12(1):12. doi: 10.3390/antibiotics12010012.
7. Almatroudi A. Biofilm Resilience: Molecular Mechanisms Driving Antibiotic Resistance in Clinical Contexts. Biology (Basel). 2025;14(2):165. doi: 10.3390/biology14020165.
8. Dudek B, Brożyna M, Karoluk M, Frankiewicz M, Migdał P, Szustakiewicz K, Matys T, Wiater A, Junka A. In Vitro and In Vivo Translational Insights into the Intraoperative Use of Antiseptics and Lavage Solutions Against Microorganisms Causing Orthopedic Infections. Int J Mol Sci. 2024;25(23):12720. doi: 10.3390/ijms252312720.
9. Tuchscherr L, Löffler B, Proctor RA. Persistence of Staphylococcus aureus: Multiple Metabolic Pathways Impact the Expression of Virulence Factors in Small-Colony Variants (SCVs). Front Microbiol. 2020;11:1028. doi: 10.3389/fmicb.2020.01028.
10. Yarets Y.I., Shevchenko N.I., Martinkov V.N. Biological properties of Stаphylococcus aureus — biofilm producers isolated from wound swabs from patients. Medical and Biological Problems of Life Activity. 2021;(2):134-143. (In Russ.)
11. Horner C, Mawer D, Wilcox M. Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter? J Antimicrob Chemother. 2012 Nov;67(11):2547-59. doi: 10.1093/jac/dks284.
12. Van den Poel B, Saegeman V, Schuermans A. Increasing usage of chlorhexidine in health care settings: blessing or curse? A narrative review of the risk of chlorhexidine resistance and the implications for infection prevention and control. Eur J Clin Microbiol Infect Dis. 2022;41(3):349-362. doi: 10.1007/s10096-022-04403-w.
13. Denkel LA, Kramer TS, Schwab F, Golembus J, Wolke S, Gastmeier P, Geffers C. Chlorhexidine and octenidine susceptibility of bacterial isolates from clinical samples in a three-armed cluster randomised decolonisation trial. PLoS One. 2022;17 (12):e0278569. doi: 10.1371/journal.pone.0278569.
14. Brown JL, Townsend E, Short RD, Williams C, Woodall C, Nile CJ, Ramage G. Assessing the inflammatory response to in vitro polymicrobial wound biofilms in a skin epidermis model. NPJ Biofilms Microbiomes. 2022;8(1):19. doi: 10.1038/s41522-022-00286-z.
15. Brill FHH, Hambach J, Utpatel C, Mogrovejo DC, Gabriel H, Klock JH, Steinmann J, Arndt A. Biofilm reduction potential of 0.02 % polyhexanide irrigation solution in several types of urethral catheters. BMC Urol. 2021;21(1):58. doi: 10.1186/s12894-021-00826-3.
16. Paleczny J, Junka AF, Krzyżek P, Czajkowska J, Kramer A, Benkhai H, Żyfka-Zagrodzińska E, Bartoszewicz M. Comparison of antibiofilm activity of low-concentrated hypochlorites vs polyhexanide-containing antiseptic. Front Cell Infect Microbiol. 2023;13:1119188. doi: 10.3389/fcimb.2023.1119188.
17. Santos DSF, Peralta-Mamani M, Brandão FS, Andrade FB, Cruvinel T, Santos PSDS. Could polyhexanide and chlorine dioxide be used as an alternative to chlorhexidine? A systematic review. Sao Paulo Med J. 2022;140(1):42-55. doi: 10.1590/1516-3180.2020.0776.R1.18052021.
18. Uruén C, Chopo-Escuin G, Tommassen J, Mainar-Jaime RC, Arenas J. Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance. Antibiotics (Basel). 2020;10(1):3. doi: 10.3390/antibiotics10010003.
19. Xue Yi, Lo D, Chang Ch, Huang M, Chien W, Lei Ya, Su Ya, Hsu P, Lai J. Effects of the bap and eno genes on the effectiveness of disinfectants against coagulase-negative staphylococci. Thaiwan Veterinary Journal. 2020;46(3):56-65. doi: 10.1142/S1682648520500055.
Review
For citations:
Gordina E.M., Shakhmatova A.D., Kasimova A.R., Toropov S.S., Bozhkova S.A. Methicillin-resistant staphylococci biofilms and the possibility of controlling them with chlorhexidine and polyhexanide: prospects for use in real clinical practice. Real-World Data & Evidence. 2025;5(2):72-82. (In Russ.) https://doi.org/10.37489/2782-3784-myrwd-075. EDN: NXKLWD